Evidence map›Paper›PMID 36186592›Full record

ArticleFrontiers in chemistry2022

Investigating the anticancer efficacy of biogenic synthesized MgONPs: An

Shams Tabrez, Azhar U Khan, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan, Torki A Zughaibi

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Eco-Friendly CuO/FeHeliyon · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. One-step preparation, characterization, and anticancer potential of ZnFeSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  11. Preparation and Properties of (ScInternational journal of molecular sciences · 2023
    Article
  12. Green biosynthesis of bimetallic selenium-gold nanoparticles usingFrontiers in bioengineering and biotechnology · 2023
    Article
  13. NanoInternational journal of nanomedicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shams TabrezKing Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Azhar U KhanDepartment of Chemistry, School of Life and Basic Sciences, SIILAS CAMPUS, Jaipur National University, Jaipur, India.
Mehboob HoqueApplied Bio-Chemistry Lab, Department of Biological Sciences, Aliah University, Kolkata, India.
Mohd SuhailKing Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohammad Imran KhanDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Torki A ZughaibiKing Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biogenic approach of synthesizing metal nanoparticles is an exciting and interesting research area with a wide range of applications. The present study reports a simple, convenient, low-cost method for synthesizing magnesium oxide nanoparticles (MgONPs) from pumpkin seed extracts and their anticancer efficacy against ovarian teratocarcinoma cell line (PA-1). The characteristic features of biogenic MgONPs were assessed by UV-visible spectrophotometry (UV-vis), X-ray powder diffraction (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The formation of spherical NPs with an average size of 100 nm was observed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Moreover, MgONPs exhibit considerable cytotoxicity with an IC

Indexed as

anticancerbiogeniccytotoxicityelectron microscopyMgONPs

Identifiers

PMID36186592
PMCPMC9520594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.